DK574287D0 - Anvendelse af et retinoid til fremstilling af et medikament til forebyggelse af glucocorticoidfremkaldt hudatrofi - Google Patents

Anvendelse af et retinoid til fremstilling af et medikament til forebyggelse af glucocorticoidfremkaldt hudatrofi

Info

Publication number
DK574287D0
DK574287D0 DK574287A DK574287A DK574287D0 DK 574287 D0 DK574287 D0 DK 574287D0 DK 574287 A DK574287 A DK 574287A DK 574287 A DK574287 A DK 574287A DK 574287 D0 DK574287 D0 DK 574287D0
Authority
DK
Denmark
Prior art keywords
retinoid
glucocorticoid
medicine
prevention
preparation
Prior art date
Application number
DK574287A
Other languages
English (en)
Other versions
DK574287A (da
Inventor
Albert M Kligman
James A Mezick
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK574287D0 publication Critical patent/DK574287D0/da
Publication of DK574287A publication Critical patent/DK574287A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK574287A 1986-11-03 1987-11-02 Anvendelse af et retinoid til fremstilling af et medikament til forebyggelse af glucocorticoidfremkaldt hudatrofi DK574287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/925,935 US4889847A (en) 1986-11-03 1986-11-03 Prevention of glucocorticoid-induced skin atrophy

Publications (2)

Publication Number Publication Date
DK574287D0 true DK574287D0 (da) 1987-11-02
DK574287A DK574287A (da) 1988-05-04

Family

ID=25452450

Family Applications (1)

Application Number Title Priority Date Filing Date
DK574287A DK574287A (da) 1986-11-03 1987-11-02 Anvendelse af et retinoid til fremstilling af et medikament til forebyggelse af glucocorticoidfremkaldt hudatrofi

Country Status (7)

Country Link
US (1) US4889847A (da)
EP (1) EP0266992A3 (da)
JP (1) JPS63152313A (da)
AU (1) AU591587B2 (da)
DK (1) DK574287A (da)
SG (1) SG50452A1 (da)
ZA (1) ZA878214B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
WO1988007857A1 (en) * 1987-04-06 1988-10-20 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid
ZA885192B (en) * 1987-08-19 1989-04-26 Hoffmann La Roche Pharmaceutical preparations
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
CA2035594A1 (en) * 1990-02-12 1991-08-13 Ronald J. Shannon Use of retinoids to minimize skin damage
US5070108A (en) * 1990-10-12 1991-12-03 Trustees Of The University Of Pennsylvania Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
EP0625045A4 (en) * 1992-02-07 1995-01-18 Albert M Kligman METHOD FOR TREATING FLAMMABLE DERMATOS.
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
CA2129773C (en) * 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
US5401811A (en) * 1994-05-03 1995-03-28 Eastman Chemical Company Continuous process for the oxidation of polyethylene
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
EP0986379A4 (en) * 1997-02-21 2002-11-13 Bristol Myers Squibb Co USE OF SUBSTITUTED (5,6) DIHYDRONAPHTHALEN COMPOUNDS WITH RETINOID-LIKE ACTIVITY FOR PREVENTING OR REDUCING ISCHEMIC DAMAGE
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
WO1999005161A1 (en) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
CA2334545A1 (en) * 1998-06-12 1999-12-16 Ligand Pharmaceuticals Incorporated Treatment of anti-estrogen resistant breast cancer using rxr modulators
HUE041585T2 (hu) 2004-09-28 2019-05-28 Avivagen Inc Kompozíciók és eljárások súlygyarapodás és táplálék konverzió elõsegítésére
PL2214656T3 (pl) * 2007-10-26 2019-06-28 Avivagen Inc. Kompozycje i sposoby wzmacniania odpowiedzi immunologicznej
CA2771204C (en) 2009-04-30 2017-09-19 Chemaphor Inc. Methods and compositions for improving the health of animals
WO2014151221A1 (en) 2013-03-15 2014-09-25 The Procter & Gamble Company Renewable thermoplastic starch - polyolefin compositions comprising compatibilizer and flexible thin films made therefrom
WO2015066588A1 (en) 2013-11-04 2015-05-07 The Procter & Gamble Company Thermoplastic polymer compositions having co-continuous plate-like morphology
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
IN142640B (da) * 1975-01-17 1977-08-06 Johnson & Johnson
GB1487543A (en) * 1975-05-11 1977-10-05 Dso Pharmachim Dermatological composition
US4126643A (en) * 1977-11-14 1978-11-21 Shell Oil Company Butadiene (1,3) conversion
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem

Also Published As

Publication number Publication date
SG50452A1 (en) 1998-07-20
AU8061387A (en) 1988-05-05
EP0266992A2 (en) 1988-05-11
EP0266992A3 (en) 1990-05-16
JPS63152313A (ja) 1988-06-24
US4889847A (en) 1989-12-26
DK574287A (da) 1988-05-04
AU591587B2 (en) 1989-12-07
ZA878214B (en) 1989-06-28

Similar Documents

Publication Publication Date Title
DK574287A (da) Anvendelse af et retinoid til fremstilling af et medikament til forebyggelse af glucocorticoidfremkaldt hudatrofi
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
KR880701571A (ko) 후방충전식 주사기
DK180790A (da) Fremstilling af farmaceutisk praeparat
DK158770C (da) Anvendelse af paroxetin til fremstilling af medikament mod fedme
DK153387A (da) Fremgangsmaade til fremstilling af laegemiddel-adsorbater
DK615988A (da) Fremgangsmaade til fremstilling af et afsvovlingsmiddel
DK299089D0 (da) Anvendelse af prostaglandiner til fremstilling af laegemidler
DK165355C (da) Fremgangsmaade til mikroindkapsling af laegemidler
DK645788D0 (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO873923L (no) Fremgangsmaate for fremstilling av et medisinsk hudpreparat
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK95489A (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
DK214089A (da) Fremgangsmaade til fremstilling af et dehydratiseret koedprodukt
DK425287A (da) Fremstilling af et farmaceutisk praeparat til behandling af kongestivt hjertesvigt
DK560989A (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK265789D0 (da) Fremstilling af et farmaceutisk praeparat
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK155682A (da) Fremgangsmaade til fremstilling af et psykotropt laegemiddel
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
KR900004555U (ko) 재사용 방지 일회용 주사기

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment